Hi-tech Pharmacal Co, Inc. (HITK) Tops Q2 EPS by 27c, Sales Exceed Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts HITK Hot Sheet
Join SI Premium – FREE
Hi-tech Pharmacal Co, Inc. (NASDAQ: HITK) reported Q2 EPS of $1.04, $0.27 better than the analyst estimate of $0.77. Revenue for the quarter came in at $56.88 million versus the consensus estimate of $51.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
- Levi (LEVI) Tops Q3 EPS by 12c; raises guidance
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
